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Regeneration of Sensory Axons
within the Injured Spinal Cord
Induced by Intraganglionic cAMP Elevation
of regeneration of the central branch of primary sensory
neurons into a peripheral nerve graft can be enhanced
when a peripheral nerve lesion is performed at the same
time (Richardson and Issa, 1984; Richardson and Verge,
1986; Oudega et al., 1994). Moreover, we previously
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2 Howard Hughes Medical Institute and demonstrated that a conditioning peripheral nerve le-
sion made at different times prior to a dorsal columnDepartments of Anatomy and Biochemistry and
Biophysics lesion, which severs the central branch of large diameter
sensory axons, results in regeneration of those fibersUniversity of California, San Francisco
San Francisco, California 94143 into and beyond the dorsal column lesion site (Neumann
and Woolf, 1999).
In the present study, we attempted to enhance the
intrinsic growth capacity of sensory neurons without
injuring the peripheral branch. We hypothesized thatSummary
the conditioning peripheral lesion increases the intrinsic
growth capacity of the injured central axons through aThe peripheral branch of primary sensory neurons re-
signaling cascade in the cell bodies in these neurons ingenerates after injury, but there is no regeneration
the DRG. Clues to relevant signaling pathways havewhen their central branch is severed by spinal cord
come from several in vitro studies. For example, weinjury. Here we show that microinjection of a mem-
previously found that one of the components of myelinbrane-permeable analog of cAMP in lumbar dorsal
that inhibits axonal regrowth in mammals, myelin-asso-root ganglia markedly increases the regeneration of
ciated glycoprotein (MAG) (McKerracher et al., 1994;injured central sensory branches. The injured axons
Mukhopadhyay et al., 1994), also repels embryonic Xen-regrow into the spinal cord lesion, often traversing the
opus spinal axons, but manipulations that stimulateinjury site. This result mimics the effect of a condition-
cAMP signaling in these axons converts this repulsioning peripheral nerve lesion. We also demonstrate that
to attraction (Song et al., 1998). Filbin and colleaguessensory neurons exposed to cAMP in vivo, when sub-
have also shown that elevated levels of cAMP secondarysequently cultured in vitro, show enhanced growth of
to neurotrophin exposure enhance the ability of a varietyneurites and an ability to overcome inhibition by CNS
of neonatal mammalian axons, including primary sen-myelin. Thus, stimulating cAMP signaling increases
sory axons, to grow on substrates of both MAG andthe intrinsic growth capacity of injured sensory axons.
myelin (Cai et al., 1999, 2001), which normally inhibitThis approach may be useful in promoting regenera-
axon regrowth. In the present study, we therefore askedtion after spinal cord injury.
whether exposing sensory neurons in the DRG to a
membrane-permeable cAMP analog, db-cAMP, could
Introduction enhance the regeneration of the central (spinal cord)
branch of primary sensory neurons. Based on our previ-
The peripheral and central (spinal cord) axonal branches ous finding that a dramatic regenerative response is
of adult primary sensory neurons differ fundamentally achieved by priming the DRG cells with a conditioning
in their response to injury: the peripheral branch regen- peripheral lesion prior to the dorsal column injury (Neu-
erates after injury, but the central branch, which courses mann and Woolf, 1999), we examined specifically
in the dorsal columns of the spinal cord, does not (Ra- whether exposure of the DRG cell bodies 48 hr prior to
mon y Cajal, 1928). The failure of the injured central the injury could stimulate regeneration. To help interpret
branch to regenerate likely has multiple causes, includ- the effects we saw, we also asked how the growth behav-
ing the presence of glial barriers and of inhibitory mole- ior of neurons was altered by this treatment, by subse-
cules (e.g., in CNS myelin) (Benfey et al., 1985; Fawcett quently removing neurons treated in vivo and culturing
and Asher, 1999; Fitch and Silver, 1997; Schwab and them on both permissive and nonpermissive substrates
Caroni, 1988; Schwab and Bartholdi, 1996) and the lack in vitro. Our results imply that exposure to db-cAMP
of some growth-promoting molecules at the injury site can alter the growth state of these neurons both in vivo
(Jakeman and Reier, 1991), as well as an inadequate and in vitro and may provide a useful tool to stimulate
intrinsic growth capacity of the injured neurons (Faw- regeneration in the injured spinal cord in vivo.
cett, 1992). Attempts have been made to enhance the
intrinsic capacity of adult sensory neurons to grow. For
Resultsexample, the extent of neurite outgrowth and the rate
Dorsal Column Tracing and Lesion
3 Correspondence: marctl@stanford.edu (M.T.-L.), aib@phy.ucsf.edu In our in vivo experiments, we used the dorsal columns
(A.I.B.) to study the regenerative capacity of CNS axons. We4 These authors contributed equally to this work.
focused specifically on medium and large diameter sen-5 Present address: Department of Biological Sciences, Howard
sory neurons with cell bodies located in the L4, L5,Hughes Medical Institute, 371 Serra Mall, Stanford University, Stan-
ford, California 94305. and L6 DRG in the lumbar spinal cord. These neurons
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Figure 1. Regeneration of the Central
Branches of Sensory Neurons In Vivo after
Intraganglionic Injection of db-cAMP
All panels (except [B]) show images from hori-
zontal sections through the thoracic spinal
cord of control or operated animals. Rostral
(anterior) to the right, caudal (posterior) to
the left. To visualize the central branches of
sciatic sensory axons coursing in the dorsal
columns, these axons are labeled by trans-
neuronal transport of B-HRP injected into the
sciatic nerve (B-HRP reaction product ap-
pears pink in dark field optics).
(A) In an unoperated animal, the fibers tra-
verse the spinal cord in a tight bundle.
(B) Transverse section through the caudal
hindbrain showing termination of the sciatic
dorsal column fibers in the gracile nucleus in
an unoperated animal. Extensive labeling in
the gracile nucleus was observed in all unin-
jured animals, whereas no labeling was ob-
served in any of the injured animals (data not
shown), confirming the completeness of the
lesion in each case.
(C and D) Horizontal section through the le-
sion site taken from a noninjected animal. The
sciatic dorsal column fibers do not enter the
lesion site.
(E and F) Horizontal section through the lesion
site taken from a saline-injected animal. The
majority of fibers stop at the lesion site, but
a few grow around the cyst ([F], arrowhead).
This example illustrates the maximum growth
that we observed in saline-treated animals.
Note that only very few fibers are present in
the lesion.
(G–J) Horizontal sections through the lesion
site taken from db-cAMP-injected animals
showing regenerating fibers. Many sciatic
dorsal column axons regrow into the lesion
site; some grow extensively around and on
the walls of a cyst (G and H), while others
grow toward the surface of the spinal cord ([I
and J], arrow). Asterisk in (G) denotes area
magnified in (H).
Scale bar: 250 m for (A), (C), (E), (G), and (I);
50 m for (B), (D), (F), (H), and (J).
possess both a peripheral branch that innervates the hind- fasciculus by injecting an anatomical tracer (the  sub-
unit of cholera toxin conjugated to horseradish peroxi-limb as well as a central branch that courses in the gracile
fasciculus (the most medial component of the dorsal dase [B-HRP]) into the sciatic nerve. This tracer is taken
up selectively by medium and large diameter myelinatedcolumns) and terminates in the gracile nucleus in the
medulla (Figure 1B). We visualized axons in the gracile axons (Robertson and Grant, 1989) and transported ret-
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2). This small amount of growth may result from injury
during injection mimicking the effect of a conditioning
lesion (see Discussion). In contrast to the results from
these control groups, when we microinjected L4/L5
DRGs with db-cAMP (1.5 l of a 10 mM solution injected
in each ganglion) 48 hr prior to dorsal column lesion,
we observed a robust regenerative response. In all cases
analyzed (n  6), massive numbers of damaged fibers
penetrated and regenerated into and across the lesion
site (Figures 1G–1J). As shown in Figure 2, the length
of the fibers was much longer than observed in controls.
A prominent feature of the regenerating fibers was a
loss of the fasciculation typical of intact dorsal column
fibers (Figures 1H and 1J). Some of the fibers in the
Figure 2. Length of the Longest Regenerating Sciatic Dorsal Col- lesion site grew along cysts (Figures 1G and 1H). Others
umn Axons Measured from the Proximal Site of the Lesion grew in the same plane as the lesion, toward the surface
No growth was observed in the lesion site in noninjected animals of the spinal cord, i.e., at a right angle to the normal
(n  6). A small number of fibers grew in the saline-injected group trajectory of the axons (Figures 1I and 1J). Occasionally,
(n 5; Figure 1F), but only for a short distance. Extensive regenera-
the regenerating axons entered adjacent dorsal rootstion of sciatic dorsal column injured axons occurred only in the db-
that were injured during the surgical interruption of thecAMP-injected group (n  6).
dorsal columns (data not shown). In addition, in this
group, sprouting proximal to the lesion site was evident
(Figure 1G and 1I), which contrasts with the controlrogradely to cell bodies in the DRG and from there an-
groups in which such sprouting was absent. Althoughterogradely into the axons of the ipsilateral gracile fas-
substantial growth of many damaged fibers was foundciculus; collateral branches of these axons can also be
within the lesion site in all animals, no regrowth wasidentified in the gray matter of the L4-6 lumbar spinal
observed beyond the lesion. Interestingly, although thisdorsal horn and projecting to Clarke’s nucleus in the
contrasts with the effects of a conditioning peripheralupper lumbar and lower thoracic segments (LaMotte et
lesion made 1 week prior to the central lesion, the extental., 1991). Importantly, above thoracic segment 8 (T8),
of regeneration observed here is comparable to thatthe axons coursing in the dorsal columns are tightly
observed following a conditioning lesion made at thefasciculated and unbranched (Figure 1A). Using micros-
same time as the central lesion (Neumann and Woolf,cissors, we transected the dorsal columns bilaterally at
1999).the level of the T6-7 thoracic segments, between the
dorsal root entry zones, under halothane anesthesia.
Ventrally, the lesions extended down to the central ca- Enhanced Outgrowth of Neurites on a Semipermissive
Substrate after Injection of db-cAMP into DRGsnal, so that the dorsal columns were transected in their
entirety. In some cases, the central canal was also dam- These results illustrate that injection of db-cAMP into
DRG can, at least in part, recapitulate the growth-pro-aged, leading to the development of cysts that extended
proximal and distal to the lesion. moting effects of conditioning sciatic nerve lesions. To
begin to address the mechanism through which db-
cAMP alters the regenerative capacity of DRG axons,Regeneration of Damaged Dorsal Column Fibers
into the Lesion Site after Injection of db-cAMP we turned to an in vitro analysis of the effects of such
manipulations on the growth capacity of DRG neurites.into DRGs
The regenerative response was assessed 6–8 weeks It has been well documented that stimulating cAMP
signaling in vitro can enhance the growth capacity ofafter dorsal column lesion. Consistent with previous re-
sults, we found no signs of regeneration of the injured both embryonic and adult sensory neurons cultured on
a permissive substrate (Rydel and Greene, 1988; Ander-axons in the dorsal columns of normal, untreated ani-
mals (n  6): in all animals, fibers abruptly stop at the sen et al., 2000). Those studies examined bulk popula-
tions of sensory neurons, whereas our in vivo studieslesion site, and most labeled axons formed a growth
cone-like swelling (end bulbs; data not shown), which focused on axons projecting in the dorsal columns,
which are the myelinated axons of medium and largenever penetrated the injury site (Figures 1C and 1D and
Figures 2). Proximal to the lesion, the dorsal column diameter DRG neurons. To address directly whether this
subpopulation is responsive to cAMP stimulation, wetract appears as a tight bundle of fibers. This baseline
pattern reflects the fact that axonal regeneration does used antibody N-52 to neurofilament 200 to selectively
mark these cells (Lawson and Waddell, 1991; Shaw etnot normally occur in the CNS (Ramon y Cajal, 1928).
Similar results were observed in rats in which the L4/ al., 1986). We plated sensory neurons dissociated from
L4 and L5 DRG on poly-D-lysine-coated dishes andL5 DRGs had been injected with saline (1.5 l in each
ganglion) 48 hr prior to dorsal column lesion: virtually treated them with forskolin to stimulate cAMP produc-
tion. At 18 hr, we observed little growth from eitherall the fibers stopped dead at the dorsal column lesion,
and the density of end bulbs in these rats was similar control or forskolin-treated cells (data not shown). After
48 hr, however, whereas control neurons displayed onlyto noninjected animals (data not shown). We did observe
some axons entering the lesion site, but they were very moderate growth (Figures 3A and 3B), there was exten-
sive outgrowth from neurons cultured with 3 or 30 Mfew in number (Figures 1E and 1F) and very short (Figure
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Figure 3. Forksolin Treatment Enhances
Axon Outgrowth from Medium and Large Di-
ameter Adult Sensory Neurons
DRG cells were plated on poly-D-lysine
coated dishes with or without forskolin for 48
hr, then fixed and stained for N-52. Control
cells show only moderate outgrowth (A and
B), while forskolin-treated cells have long ax-
ons (C and D). (E) The response to forkskolin
treatment, quantified as the length of the lon-
gest N-52 neurite per cell, saturates by 3
M. The mean length values were obtained
from three independent experiments. Scale
bar: 100 m.
forskolin (Figures 3C–3E) (p  0.004, Student’s t test). ures 4A, 4E, and 4F). A slight response of neurons to
saline injection was observed: the number of neuronsThus, stimulation of cAMP signaling in vitro can increase
with neurites (defined as processes 30 m) increasedthe growth capacity of medium and large diameter
from 6.5% 0.7% (noninjected) to about 18.9% 2.2%N-52 adult sensory neurons.
(saline injected; Figures 4B and 4E) (p 0.02, Student’s tWe next examined more specifically whether the in
test). However, the distribution of neurite lengths amongvivo manipulation we had performed, the injection of
neurite-bearing neurons was not markedly changeddb-cAMP into DRG, also results in an enhancement of
(Figure 4F). The slight difference between control andthe growth properties of the neurites of those neurons.
saline-treated groups parallels the slight difference ob-For this, we unilaterally injected the L4 and L5 ganglia
served in vivo (Figures 1 and 2). In contrast to the verywith db-cAMP; 48 hr later, the rats were killed, the in-
poor growth observed in these control groups, after 18jected and the contralateral noninjected (control) L4 and
hr we observed extensive growth of N-52 neurites fromL5 sensory ganglia were separately pooled and dissoci-
neurons treated in vivo with db-cAMP (Figure 4C), asated, and the neurons were plated on poly-D-lysine.
49.7%  4.3% of neurons now had neurites (Figure 4E)
As a further control, we cultured neurons from ganglia
(p  0.0001 for comparison with either saline treatment
injected with saline. In a previous study, Smith and or control). Furthermore, the length of the neurites was
Skene showed that when control adult sensory neurons significantly increased: for example, the fraction of all
are cultured on a permissive substrate, there is a 20–24 N-52 neurons in the cultures with neurites greater than
hr lag before they extend neurites in a significant way, 250 m in length increased from 0.1%  0.05% and
but that this time can be shortened if neurons are sub- 0.85%  0.2% for control or saline-treated conditions,
jected to peripheral nerve injury 2–7 days before plating respectively, to 6.5%  0.7% for the db-cAMP-treated
(Smith and Skene, 1997). We therefore chose to examine condition (p  0.0003). This increase did not merely
the neurons after 18 hr in culture, to determine whether, reflect the fact that more neurons had neurites in the
as with the conditioning lesion, the pretreatment with db-cAMP-treated case, but also reflected the fact that
db-cAMP could affect the timing of onset and/or rate neurites that extended from these neurons were longer
of extension of the axons. than in controls. This was shown by the analysis of
As expected, little outgrowth was observed after 18 Figure 4F, in which we focused only on neurons with
neurites (processes 30 m), a procedure that will tendhr from N-52 neurons from noninjected ganglia (Fig-
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Figure 4. Injection of db-cAMP into DRGs In Vivo or a Conditioning Peripheral Nerve Lesion Enhances Neurite Outgrowth on a Permissive
Substrate
(A–D) L4 and L5 DRG were injected unilaterally with 1.5 l of 10 mM db-cAMP or saline. 2 days later, the DRGs were removed, dissociated,
and plated on poly-D-lysine-coated dishes. After 18 hr, cells were fixed and stained for N-52. DRG neurons obtained from noninjected (n 
8) (A) or saline-injected (n  8) (B) ganglia have either no or only very short neurites at this time point. In contrast, many DRG neurons from
db-cAMP-injected DRG (n  8) (C) or from DRG in which a conditioning peripheral nerve lesion had been performed (n  4) (D) extend far
and often have numerous axons.
(E) Percent neurons with N-52 neurites (process  30 m) under different conditions.
(F) Distribution of neurite lengths among neurons with neurites 30 m under different conditions (n  4).
Scale bar, 100 m.
to overemphasize the contributions of the small number hr provides evidence that exposure to db-cAMP, like
the conditioning lesion, can put these neurons into whatof neurons with neurites in control and saline-treated
conditions. Even within these populations of neurite- Smith and Skene have termed a state of “competence
for axonal growth” (Smith and Skene, 1997). To permitbearing neurons, a significant shift in the distribution
of lengths was observed following db-cAMP treatment, a more direct comparison of the effects of db-cAMP
treatment to that of a conditioning lesion, we performedwith a significant decrease in the fraction in the 31–80
m range (p  0.002 for db-cAMP treatment compared conditioning lesions of the sciatic nerve, and 48 hr later
we cultured neurons from L4 and L5 DRG. After 18 hr,to either control or saline-treated), and a concomitant
rise in the fraction with lengths in the 151–250 m range similar numbers of neurons with neurites were observed
following a conditioning lesion (53.7%  4.3%) and fol-and the 250 m range (Figure 4F) (p  0.004 for the
number in either of those length bins when compared lowing db-cAMP treatment (49.7%  4.3%, Figure 4E)
(p  0.4). Again, when we focused just on neurons withto control or saline-treated; Figure 4F). Thus, the db-
cAMP treatment increases both the number of process- neurites greater than 30 m in length, there was also a
significant increase in the lengths of neurites comparedbearing cells at 18 hr, as well as the lengths of neurites
of those cells. to control and saline-injected groups (Figures 4D and
4E), including a significant increase in the number ofOur finding that a large fraction (50%) of the neurons
exposed to db-cAMP extended neurites in vitro at 18 neurons with neurites greater than 250 m (Figure 4F)
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(p  0.003, when compared to either control or saline- again more than doubled compared to control or saline-
injected [p  0.002 in both cases]).injected). Although the trend appeared to be that neurite
lengths were slightly greater after the conditioning lesion
treatment than after the db-cAMP treatment, the differ- Discussion
ences between the two groups were not significant (p
0.14 for each neurite length bin). Our results show that injection of db-cAMP into adult
sensory ganglia prior to lesioning their central processes
can endow the treated sensory neurons with the abilityEnhanced Outgrowth of Neurites on an Inhibitory
Substrate after Injection of db-cAMP into DRGs to regenerate injured axons into the adult CNS in vivo.
Based on our in vitro results, we suggest that there areBecause the environment in which sensory axons regen-
erate after CNS injury is inhibitory, we next asked two key mechanisms through which stimulation of cAMP
signaling promotes in vivo regeneration: increasing thewhether cAMP pretreatment in vivo could also subse-
quently enable the neurons to extend neurites on an intrinsic growth capacity of the axons (manifested by
an earlier onset of robust axon outgrowth) and enablinginhibitory substrate. Dissociated L4/L5 sensory neurons
obtained from rats injected as above with db-cAMP them to overcome the effects of inhibitory factors at the
lesion site. (Strictly speaking, in our in vitro studies wewere plated on a substrate of poly-D-lysine and myelin,
a well-known inhibitory substrate (Schwab and Caroni, showed that the cyclic nucleotide treatment can over-
come the inhibitory effect of myelin, and for technical1988). Because normal growth is significantly attenu-
ated on the myelin substrate, in these experiments, we reasons we did not test its ability to overcome inhibition
by injury site tissue, but the fact that regeneration occursassessed neurite outgrowth after 36 hr rather than after
18 hr in culture. At 36 hr, virtually no outgrowth was through that tissue in vivo supports the possibility that
the treatment is overcoming inhibition there as well.)observed from noninjected N-52 neurons (Figures 5A,
5E, and 5F). As on a permissive substrate, when N-52 Despite the profuse outgrowth of neurites into the lesion
site, in this particular paradigm we did not observeneurons from saline-injected neurons were grown on a
myelin substrate, we also observed a very slight but growth rostral to the lesion site, as has been observed
when a sciatic nerve lesion is made 1 week prior to thestatistically significant increase in the number of neu-
rons with neurites, from 4.6%  1.0% to 8.5%  1.3% dorsal column lesion. Because we used only one dose
of db-cAMP and one time point, it is conceivable that(Figures 5B and 5E) (p 0.02), although not a detectable
change in the length of the neurites of cells with neurites increasing the dose administered or changing the time
window might allow the severed axons to grow not justgreater than 30 m (Figures 5F). In contrast to the poor
growth observed for those two sets of neurons, N-52 through but also beyond the lesion site. Consistent with
this possibility, the magnitude of the regeneration thatneurons from DRG injected with db-cAMP showed ex-
tensive growth on myelin (Figure 5C), with a marked we observed is comparable to that seen when the condi-
tioning sciatic nerve lesion is made at the same time asincrease in the number of neurons with neurites to
29.4%  4.3% (Figure 5E) (p  0.0001 for comparison the dorsal column lesion (Neumann and Woolf, 1999),
supporting the possibility of a dose and time depen-to either control or saline-treated cases). There was also
a significant increase in the length of the neurites. For dency to the effect of the manipulations. Indeed, based
on the results reported by Filbin and colleagues (Qiu etexample, among all N-52 neurons, the fraction with
neurites greater than 150 m increased from 0.6%  al., 2002, this issue of Neuron), cAMP-induced growth
beyond the lesion site is clearly possible and appears0.2% or 1.2%  0.2% for control or saline-treated, re-
spectively, to 10.0%  1.1% for the db-cAMP-treated to be related to the dose of cAMP injected and to the
time between the injection and the spinal cord injury.neurons (p  0.0003 in both cases)—an 8- to 16-fold
increase. As in the case of growth on a permissive sub- We have not assessed whether the cAMP treatment also
affects the growth of the peripheral branch in vivo.strate, this increase did not merely reflect the fact that
more neurons had neurites, but also reflected the fact The parallels between the effects of db-cAMP injec-
tion into DRG and the effects of a conditioning peripheralthat neurites that extended from these neurons were
longer than in controls. This was shown by the analysis nerve lesion are striking. Each manipulation increases
the intrinsic growth capacity of sensory neurons, suchof Figure 5F, in which we focused just on the neurons
with neurites greater than 30 m. Even within those that they extend axons more rapidly when placed in
culture. Each manipulation also promotes an increasedpopulations, there was also a statistically significant in-
crease (more than double) in the fraction of neurons rate of extension of the axons on a permissive substrate
and an ability to counteract the inhibitory effects of my-with neurites greater than 150 m in the db-cAMP-
treated case compared to control or saline-injected (p elin. Each of these factors, we believe, contributes to
our most important finding, namely that either the condi-0.005 in both cases). As was perhaps expected, similar
results were obtained for neurons derived from rats sub- tioning lesion or direct injection of db-cAMP into the
DRG allows for profuse regeneration of the centraljected to a conditioning sciatic nerve lesion, when cul-
tured on myelin: we observed a statistically significant branches of injured sensory axons through a spinal cord
lesion site. Based on these parallels, we propose thatincrease in the number of neurons with neurites greater
than 30 m to 33.1%  3.8% (Figures 5D and 5E) (p  the effects of the conditioning lesion are mediated at
least partly by stimulation of cAMP levels in the sensory0.0001 when compared to either control or saline-
injected) and a statistically significant increase in the neurons, a possibility that needs to be directly tested.
Conversely, the fact that in the saline-injected group alength of neurites (Figure 5F) (e.g., among neurons with
neurites, the fraction with neurites greater than 150 m few fibers penetrated the lesion site (though only for
cAMP-Induced Regeneration of Spinal Sensory Axons
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Figure 5. Injection of db-cAMP into DRGs In Vivo or a Conditioning Peripheral Nerve Lesion Enables Axons to Grow on an Inhibitory Substrate
(A–D) L4 and L5 DRG were injected with 1.5 l of 10 mM db-cAMP or saline. 48 hr later, the DRG were removed, dissociated, and plated on
myelin-coated dishes precoated with poly-D-lysine. To establish the inhibitory effect of myelin compared to a permissive substrate, dissociated
neurons from noninjected (control) animals were also plated on dishes only coated with poly-D-lysine (n  4). After 36 hr in culture, cells were
fixed and stained for N-52. Whereas noninjected neurons plated on poly-D-lysine alone show robust outgrowth at this time (see [E]), neurons
obtained from either noninjected (n  8) (A) or saline-injected (n  6) (B) DRG neurons plated on poly-D-lysine and myelin show either no or
very little neurite outgrowth. In contrast, many neurons derived from db-cAMP-injected DRG (n  6) (C) or from DRG in which a conditioning
peripheral nerve lesion had been performed (n  7) (D) show robust axonal growth.
(E) Percent neurons with N-52 neurites (processes  30 m) under different conditions.
(F) Distribution of neurite lengths among neurons with neurites 30 m under different conditions (n  4).
Scale bar, 100 m.
a short distance) suggests that the injection caused a there is every reason to believe that the effect is medi-
ated at least partly, and perhaps entirely, by effects onslight injury of the DRG cells that might be tantamount
to a slight conditioning lesion (and the response to which the neurons themselves. We suggest this because of the
previous demonstration that cAMP stimulation in themight even be mediated by stimulation of cAMP signal-
ing in the cells). It should be emphasized, however, that neurons in vitro (either at the level of individual growth
cones or in low-density cultures) can help overcome anthe slight response seen in the saline-injected group is
markedly different from the striking regenerative re- inhibitory substrate (Song et al., 1998; Cai et al., 1999,
2001; this study), and because of the evidence that ansponse observed in the db-cAMP-treated group, in
which a substantial number of fibers regenerated exten- intrinsic decrease in cAMP levels in a variety of neurons
underlies their loss of regenerative ability (Cai et al.,sively into the lesion site in each animal analyzed.
Although we have interpreted our results as if they 2001). Future studies in which cAMP signaling is specifi-
cally modulated in neurons in vivo will help address theare due to stimulation of cAMP signaling in the neurons,
we cannot, of course, exclude that part of the effect of contributions of effects on the neurons (cell-autono-
mous) and effects on nonneuronal cells (nonautono-the in vivo injection could have resulted from effects of
the db-cAMP on nonneuronal cells in the DRG, which mous), although it will always be difficult to exclude the
possibility that even the response to a cell-autonomousthen somehow indirectly affected the neurons. However,
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ing all neurons derived from each rat (1000 cells/rat). For lengthmanipulation may yet involve some communication be-
distribution, approximately 200 cells per animal were randomly se-tween the altered neuron and its neighboring nonneu-
lected and their images captured using a Spot 2-RT digital cameraronal cells.
(Diagnostic Instruments, Michigan). Axon length was measured us-
In summary, our results provide evidence that manipu- ing calibrated Spot software.
lation of a specific signal transduction pathway in neu-
rons can promote significant axonal regeneration in the DRGs Microinjection
Under halothane anesthesia, a small dorsolateral laminectomy wasCNS environment in vivo. Although we have focused
performed in order to expose the left L4-L5 DRGs. Using a recordingon the cAMP signaling pathway, it will be important to
glass pipette, the DRGs were gently punctured. 1.5 l of saline orassess whether additional manipulations of signaling
db-cAMP (10 mM) were slowly injected into the DRGs using a 5 lpathways help regeneration further, including stimula- hamilton syringe with a 30G needle. The wound was then closed,
tion of cGMP signaling, which can help overcome the and the rats were allowed to recover. For the in vivo experiments,
effects of other repulsive factors such as Slits (Ba-Char- 48 hr later these rats underwent dorsal column lesions as described
above. For the culture experiments, 48 hr later the rats were sacri-vet et al., 2001) and Semaphorins (Song et al., 1998),
ficed and the DRGs placed in culture conditions as described above.some of which are known to be expressed at CNS lesion
Dorsal column lesion, peripheral nerve lesion, in vivo axonal trac-sites (Pasterkamp et al., 1999). In addition, from the
ing, and tissue processing were all performed exactly as describedperspective of clinical application, it will, of course, be (Neumann and Woolf, 1999).
important to determine whether regeneration can be
enhanced by stimulating cAMP signaling after spinal Quantification of the Regenerative Response
cord injury. Nevertheless, our results suggest that stimu- Camera lucida reconstructions of horizontal sections of the lesion
site from each animal were used to measure the length of the regen-lating cyclic nucleotide signaling pathways to enhance
erative response of the sciatic dorsal column axons into the lesionthe growth capacity of injured CNS axons and to over-
site (Figure 2).come the barriers associated with sites of injury may
be a useful component of a therapy to enhance axonal
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